EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Human ex vivo comparison of Escherichia coli and Pseudomonas aeruginosa lipopolysaccharide–induced immune responses and cefiderocol effects in whole blood

Lena Pracher, Anselm Jorda, Sabine Eberl, Maria Weber, Markus Zeitlinger

Medical Microbiology and Immunology · 2026-12 · 215 (1)

DOI: 10.1007/s00430-026-00883-1 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Medical Microbiology and Immunology, online erschienen am 27.07.2026. Verfasst von Lena Pracher und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. Hauptthemen laut MEDLINE: Lipopolysaccharides, Escherichia coli, Cytokines, Cephalosporins. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Vienna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune dysregulation is central in bacterial sepsis with lipopolysaccharide (LPS) of gram-negative bacteria acting as a key component in innate immune activation. Modulation of the host response by potential immunomodulatory agents may confer benefits. This ex vivo study compared cytokine responses induced by E. coli and P. aeruginosa LPS and evaluated the impact of cefiderocol on LPS-induced immune activation in human whole blood. Whole blood from ten healthy volunteers was stimulated ex vivo with E. coli or P. aeruginosa LPS in the presence or absence of cefiderocol and incubated for 4 h at 37 °C. Plasma concentrations of TNF-α, IL-1β, IL-6, IL-10, IFN-α, IFN-γ, and IL-8 were quantified at 0 h, 2 h, and 4 h using a multiplex immunoassay. Cytokine release was significantly higher after E. coli LPS stimulation than with P. aeruginosa LPS across all analytes. Mean TNF-α area under the curve (AUC₀–₄) was 2379 pg*h/mL with cefiderocol vs 1936 pg*h/mL without (percent difference 18.2% [95% CI, 5.9–31.4]) after E. coli LPS stimulation, and 278 pg/mL vs 242 pg*h/mL (12.9% [4.3–21.5]) after P. aeruginosa LPS stimulation. For IL-6, cefiderocol slightly increased AUC₀–₄ following E. coli LPS stimulation (4584 vs 3635 pg*h/mL; 20.7% [8.3–33.0]) but not with P. aeruginosa LPS (184 vs 201 pg*h/mL; − 9.3% [− 53.7–35.2]). IL-1β, IL-10, IFN-α, IFN-γ, and IL-8 levels were mostly unaffected by cefiderocol. Cefiderocol did not suppress cytokine release in human whole blood. In this study, E. coli LPS elicited a stronger immune response than P. aeruginosa LPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesEscherichia coliCytokinesCephalosporinsPseudomonas aeruginosaBloodImmunologic FactorsHumansCefiderocolMaleAdultFemaleHealthy Volunteers

Stichwörter der Autor:innen

AntibioticCytokineImmune systemSepsis

Substanzen

CefiderocolLipopolysaccharidesCytokinesCephalosporinsImmunologic Factors

Autor:innen und Institutionen

  • Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.
  • Department of Clinical Pharmacology, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria. markus.zeitlinger@meduniwien.ac.at.

Förderung

  • Medical University of Vienna

Zitieren

APA

Pracher, L., Jorda, A., Eberl, S., Weber, M., & Zeitlinger, M. (2026). Human ex vivo comparison of Escherichia coli and Pseudomonas aeruginosa lipopolysaccharide–induced immune responses and cefiderocol effects in whole blood. Medical Microbiology and Immunology, 215(1). https://doi.org/10.1007/s00430-026-00883-1

Vancouver

Pracher L, Jorda A, Eberl S, Weber M, Zeitlinger M. Human ex vivo comparison of Escherichia coli and Pseudomonas aeruginosa lipopolysaccharide–induced immune responses and cefiderocol effects in whole blood. Medical Microbiology and Immunology. 2026;215(1). doi:10.1007/s00430-026-00883-1

BibTeX
@article{Pracher2026,
  author = {Pracher, Lena and Jorda, Anselm and Eberl, Sabine and Weber, Maria and Zeitlinger, Markus},
  title = {Human ex vivo comparison of Escherichia coli and Pseudomonas aeruginosa lipopolysaccharide–induced immune responses and cefiderocol effects in whole blood},
  journal = {Medical Microbiology and Immunology},
  year = {2026},
  volume = {215},
  number = {1},
  doi = {10.1007/s00430-026-00883-1}
}
Kostenlos starten →